Cytogenetic, interphase, and multicolor fluorescence in situ hybridization analyses in primary plasma cell leukemia: a study of 40 patients at diagnosis, on behalf of the Intergroupe Francophone du Myélome and the Groupe Français de Cytogénétique Hématologique
- PMID: 11157506
- DOI: 10.1182/blood.v97.3.822
Cytogenetic, interphase, and multicolor fluorescence in situ hybridization analyses in primary plasma cell leukemia: a study of 40 patients at diagnosis, on behalf of the Intergroupe Francophone du Myélome and the Groupe Français de Cytogénétique Hématologique
Abstract
Primary plasma cell leukemia (PCL) is a rare plasma cell malignancy. Consequently, few large reports have been published. Presented is a cytogenetic analysis of 40 patients with primary PCL compared with 247 newly diagnosed patients with stage III multiple myeloma (MM). Cytogenetic abnormalities were observed in 23 of 34 patients, with usually complex hypodiploid or pseudodiploid karyotypes. Analysis of rearrangements of the 14q32 region revealed significant differences with high cell mass MM-a higher incidence of t(11;14) (33% vs 16%; P <.025) and of t(14;16) (13% vs 1%; P <.002) though incidences of t(4;14) were identical and a higher incidence of monosomy 13 (68% vs 42%; P =.005). Hypodiploid karyotypes and monosomy 13 may explain, at least in part, the poorer prognosis of primary PCL. In contrast, significantly longer survival was observed in patients displaying t(11;14) in comparison with those lacking this translocation (P =.001).
Similar articles
-
Monosomy 13 is associated with the transition of monoclonal gammopathy of undetermined significance to multiple myeloma. Intergroupe Francophone du Myélome.Blood. 1999 Oct 15;94(8):2583-9. Blood. 1999. PMID: 10515861
-
The Ig heavy chain gene is frequently involved in chromosomal translocations in multiple myeloma and plasma cell leukemia as detected by in situ hybridization.Blood. 1997 Jul 15;90(2):526-34. Blood. 1997. PMID: 9226151
-
Fluorescence in situ hybridization analysis of aneuploidization patterns in monoclonal gammopathy of undetermined significance versus multiple myeloma and plasma cell leukemia.Cancer. 2003 Feb 1;97(3):601-9. doi: 10.1002/cncr.11100. Cancer. 2003. PMID: 12548602
-
Non-random chromosomal rearrangements and their implications in clinical features and outcome of multiple myeloma and plasma cell leukemia.Leuk Lymphoma. 1996 Mar;21(1-2):25-30. doi: 10.3109/10428199609067575. Leuk Lymphoma. 1996. PMID: 8907265 Review.
-
Cytogenetics in the management of multiple myeloma: an update by the Groupe francophone de cytogénétique hématologique (GFCH).Ann Biol Clin (Paris). 2016 Oct 1;74(5):588-595. doi: 10.1684/abc.2016.1178. Ann Biol Clin (Paris). 2016. PMID: 27707673 Review. English.
Cited by
-
High-output cardiac failure revealing primary plasma cell leukemia.Case Rep Hematol. 2013;2013:504612. doi: 10.1155/2013/504612. Epub 2013 Mar 4. Case Rep Hematol. 2013. PMID: 23533848 Free PMC article.
-
Localized Relapse of Primary Plasma Cell Leukaemia in the Central Nervous System.Case Rep Hematol. 2015;2015:273565. doi: 10.1155/2015/273565. Epub 2015 May 10. Case Rep Hematol. 2015. PMID: 26064713 Free PMC article.
-
Molecular Classification and Pharmacogenetics of Primary Plasma Cell Leukemia: An Initial Approach toward Precision Medicine.Int J Mol Sci. 2015 Jul 30;16(8):17514-34. doi: 10.3390/ijms160817514. Int J Mol Sci. 2015. PMID: 26263974 Free PMC article. Review.
-
Immunoglobulin D Multiple Myeloma: A Rare Variant.Cureus. 2022 Feb 4;14(2):e21912. doi: 10.7759/cureus.21912. eCollection 2022 Feb. Cureus. 2022. PMID: 35273861 Free PMC article.
-
A clinical perspective on plasma cell leukemia; current status and future directions.Blood Cancer J. 2021 Feb 4;11(2):23. doi: 10.1038/s41408-021-00414-6. Blood Cancer J. 2021. PMID: 33563906 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials